Clinically, CREBBP and EP300 variants are frequently reported in DLBCL patients, are often mutually exclusive, and contribute to disease relapse and inferior prognosis (Juskevicius et al., 2017). The gene discussed is CREBBP; the disease is diffuse large B-cell lymphoma.